Synthes and Kensey Nash sign ECM products agreement
This article was originally published in Clinica
Swiss orthopaedic specialist Synthes has broadened its offering of biomaterial products after signing a distribution agreement for products based on Kensey Nash’s extracellular matrix (ECM) technology. Under the terms of the deal, Kensey Nash (Exton, Pennsylvania) will use its technology for processing porcine-derived ECM tissues to develop and manufacture products, which Synthes will then market and distribute for certain reconstructive surgical applications. According to Synthes, the ECM products can be quickly repopulated with cells from the host tissue due to rapid revascularisation characteristics. The biomaterial is to be used in a wide of soft tissue reinforcement procedures, such as abdominal repairs and head, neck and chest reconstructions. Financial terms of the partnership were not disclosed.